Imran Talat has filed 19 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 1053000 shares of Rani Therapeutics Holdings, Inc. ($RANI) on May 23, 2025.
Activity breakdown: 6 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | A | Stock Option (Right to Buy) | 1053000 | $0.00 | 1,053,000.0000 | 33,509,827 | 9999.99% | 3.14% |
| Dec. 9, 2024 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | P | Class A Common Stock | 10296 | $1.94 | 494,751.0000 | 0 | 2.13% | 0.00% |
| March 21, 2024 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | A | Stock Option (Right to Buy) | 1085000 | $0.00 | 1,085,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | D | Stock Option (Right to Buy) | 479667 | $0.00 | 95,933.0000 | 0 | 83.33% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | A | Stock Option (Right to Buy) | 479667 | $0.00 | 479,667.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | D | Stock Option (Right to Buy) | 153650 | $0.00 | 109,750.0000 | 0 | 58.33% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | A | Stock Option (Right to Buy) | 153650 | $0.00 | 153,650.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | D | Stock Option (Right to Buy) | 271875 | $0.00 | 453,125.0000 | 0 | 37.50% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | A | 271875 | 271875 | $0.00 | 271,875.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | D | Stock Option (Right to Buy) | 31252 | $0.00 | 47,699.0000 | 0 | 39.58% | 0.00% |
| Dec. 16, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | A | Stock Option (Right to Buy) | 31252 | $0.00 | 31,252.0000 | 0 | 9999.99% | 0.00% |
| Dec. 6, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | P | Class A Common Stock | 10000 | $2.27 | 484,455.0000 | 0 | 2.11% | 0.00% |
| Dec. 4, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | P | Class A Common Stock | 5000 | $2.57 | 474,455.0000 | 0 | 1.07% | 0.00% |
| Nov. 29, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | P | Class A Common Stock | 20000 | $2.05 | 469,455.0000 | 0 | 4.45% | 0.00% |
| Nov. 7, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | P | Class A Common Stock | 2500 | $1.98 | 446,955.0000 | 0 | 0.56% | 0.00% |
| Nov. 7, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | Chief Executive Officer | P | Class A Common Stock | 2500 | $2.01 | 449,455.0000 | 0 | 0.56% | 0.00% |
| March 27, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | CEO | A | Class A Common Stock | 353500 | $0.00 | 444,445.0000 | 0 | 388.70% | 0.00% |
| March 27, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | CEO | A | Stock Option (Right to Buy) | 575600 | $0.00 | 575,600.0000 | 0 | 9999.99% | 0.00% |
| March 22, 2023 | Rani Therapeutics Holdings, Inc. | $RANI | Imran Talat | CEO | F | Class A Common Stock | 7988 | $5.95 | 90,945.0000 | 0 | 8.07% | 0.00% |